Cumberland Pharmaceuticals (CPIX) Intangibles (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Intangibles data on file, last reported at $12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 24.69% year-over-year to $12.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.8 million (down 24.69% YoY), and the FY2025 full-year result was $14.0 million, down 21.95% from the prior year.
• Intangibles declined to $12.8 million in Q1 2026, from $14.0 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $34.5 million in Q1 2022 to a low of $12.8 million in Q1 2026.
• A 5-year average of $22.9 million and a median of $21.5 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles rose 27.7% in 2022 and dropped 28.41% in 2024, its largest moves.
• Tracing CPIX's Intangibles over 5 years: stood at $30.6 million in 2022, then slipped by 26.1% to $22.6 million in 2023, then dropped by 20.5% to $18.0 million in 2024, then retreated by 21.95% to $14.0 million in 2025, then decreased by 8.8% to $12.8 million in 2026.
• Business Quant data shows CPIX's Intangibles at $12.8 million in Q1 2026, $14.0 million in Q4 2025, and $15.0 million in Q3 2025.